RecruitingHypothalamic ObesityPrader-Willi SyndromePWS
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Eligible age
12–65 yrs
Accepts
All genders
Locations
6 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate the safety, tolerability, and PK of RM-718 in healthy subjects with obesity and in patients with MC4R Pathway Impairment
Sponsor: Rhythm Pharmaceuticals, Inc.
Where it's recruiting
Source: ClinicalTrials.gov · NCT06239116 · last updated 2025-12-22